جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

95 مُخرَج نتائج البحث عن «Biology»

مقالوصول مفتوح20262استشهاد· Semantic Scholar

Novel anti-virulence strategy against Helicobacter pylori using Lactiplantibacillus plantarum cell-free supernatants

Frontiers in Microbiology · مجلد 17 · 1881796-1881796

Helicobacter pylori is one of the most prevalent pathogenic microorganisms worldwide. The treatment of H. pylori infections is challenging due to the increasing antibiotic resistance. Therefore, alternative therapies are crucial for addressing these issues. This study aimed to investigate alternative approaches to combat H. pylori infection using lactic acid bacteria. Nineteen LAB isolates exhibited strong tolerance to simulated gastric acid and bile salts, as well as notable auto-aggregation and co-aggregation capabilities. Among them, isolates L20, L22, and L40 showed superior performance. Their neutralized cell-free supernatants (n-CFSs) significantly inhibited H. pylori urease production by 69, 66, and 67%, respectively, and reduced biofilm formation by 88, 82, and 80%, respectively. Molecular identification revealed that isolates L20 and L40 belonged to Lactiplantibacillus plantarum , while L22 was identified as Limosilactobacillus fermentum . Furthermore, the n-CFS of L. plantarum L20 markedly downregulated the expression of H. pylori virulence genes, including vacA , cagA , ureA , and babA, with fold reductions of 79, 68, 90, and 96%, respectively. In vivo , treatment with L. plantarum L20 n-CFS resulted in 1.28 log reduction in H. pylori colonization ( p < 0.001). Proteomic analysis further identified metabolically active proteins associated with catalytic and secondary metabolite pathways, supporting their mechanistic role in anti- H. pylori activity. These findings highlight the potential of LAB-derived n-CFS, particularly L. plantarum L20, as a promising antivirulent strategy against H. pylori infections.

Helicobacter pylorianti-virulence strategiesLactobacillus plantarumcell-free supernatant
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Pulmonary and extra-pulmonary infections caused by classical and hypervirulent Klebsiella pneumoniae: a prospective cross-sectional study

Frontiers in Microbiology · مجلد 16 · 1707017-1707017

Aim Klebsiella pneumoniae ( K. pneumoniae ) is an opportunistic pathogen causing infections ranging from pulmonary disease to severe systemic illness. This study aimed to examine the relationships between infection site, pathotype, virulence, resistance, and clinical presentations to manage classical (cKp) and hypervirulent (hvKp) strains. Methods and results 600 clinical specimens were screened for K. pneumoniae . Virulence and resistance fitness were analyzed phenotypically and genotypically. Clinical correlations were assessed to link pathotype, resistance, virulence, infection site, age, and presentation. K. pneumoniae was detected in 17.2% specimens (103/600), with pulmonary samples showing 43% positivity versus 12% in extra-pulmonary ones. hvKp accounted for 55.3% and cKp for 44.7% of isolates; hvKp predominated in extra-pulmonary infections (83.3%) and cKp in pulmonary cases (83.7%). K1 (33.1%) and K2 (21.4%) were confined to hvKp, while pulmonary isolates were mainly K3, K5, and K20. Pulmonary infections mainly affected adults (81.4%) and showed respiratory signs; extra-pulmonary cases occurred mostly in pediatric (46.7%) and elderly (41.7%) patients with systemic symptoms such as fever and hypotension. Clustering distinguished pulmonary/cKp (MDR-rich) from extra-pulmonary/hvKp (virulence-rich) isolates, with some overlap indicating hybrid strains. Correlations linked pulmonary infections with cKp and MDR (r = 0.67), and extra-pulmonary infections with hvKp and systemic disease (r = 0.67). Conclusion The high MDR burden of cKp underscores the need for stronger antimicrobial stewardship and new therapies, while the invasive nature of hvKp highlights the importance of early recognition and rapid intervention to prevent systemic complications. Early distinction of cKp from hvKp can significantly influence treatment decisions and reduce morbidity and mortality associated with K. pneumoniae infections.

Klebsiella pneumoniaehypervirulent Klebsiella pneumoniaepulmonary infectionmultidrug resistance
تصحيحوصول مفتوح2026

Correction: Molecular epidemiology of carbapenemase-producing gram-negative bacilli in diabetic foot infections: association with glycemic control

Frontiers in Cellular and Infection Microbiology · مجلد 16

Correction on: Othman G, A. Badawy A, Hamed Al-Serwi R, El Sayed Zaki M, Tharwat Abou Elkhier N, Alkassaby NM and Saleh Ismail M (2026) Molecular epidemiology of carbapenemaseproducing gram-negative bacilli in diabetic foot infections: association with glycemic control. Front. Cell. Infect. Microbiol. 16:1847743. doi: 10.3389/fcimb.2026.1847743.Grant/funding/project number incorrect An incorrect number was provided for the Deanship of Scientific Research at Northern Border University, Arar, Saudi Arabia. The correct number is NBU-FFR-2026-52-03The original version of this article has been updated.

diabetic foot infectionglycemic controlmolecular epidemiologyantimicrobial resistance
مقالوصول مفتوح2026

Molecular epidemiology of carbapenemase-producing gram-negative bacilli in diabetic foot infections: association with glycemic control

Frontiers in Cellular and Infection Microbiology · مجلد 16 · 1847743-1847743

Background Carbapenem-resistant Gram-negative bacilli are an increasing threat in diabetic foot ulcer (DFU) infections, limiting therapeutic options and worsening outcomes. However, data linking specific carbapenemase genes to clinical and metabolic factors remain limited. Objectives To isolate Gram-negative bacilli from deep tissue biopsies of DFUs, determine carbapenem susceptibility by minimum inhibitory concentration (MIC) testing, detect major carbapenemase genes by multiplex qPCR, and evaluate their association with glycemic control and Wagner grade. Methods This cross-sectional study included 150 patients with infected DFUs. Isolates recovered from tissue and other specimens were identified by standard microbiological methods, and carbapenem susceptibility was assessed by MIC testing. Multiplex qPCR was used to detect bla KPC, bla NDM, bla OXA-48, bla VIM, and bla IMP, and associations between resistance determinants and clinical variables were analyzed statistically. Results The mean patient age was 56.4 ± 9.8 years, with a male predominance (61.3%), and high-grade ulcers (Wagner III–V) were present in 54.7% of patients. Klebsiella pneumoniae predominated (60.0%), followed by Pseudomonas aeruginosa and Escherichia coli (each 14.7%). Resistance to meropenem and imipenem was high (77.3% and 75.3%, respectively), and carbapenemase production was detected in 84.0% of isolates. bla KPC (28.0%) and bla NDM (24.0%) were the most prevalent genes and were significantly associated with phenotypic carbapenemase production (P = 0.002 and P = 0.006, respectively). Carbapenemase producers showed significantly higher fasting glucose and HbA1c levels than non-producers (P < 0.001), with no significant association observed for Wagner grade (P = 0.570). Conclusions DFUs showed a high burden of carbapenemase-producing Gram-negative bacilli, driven mainly by bla KPC and bla NDM. Poor glycemic control was strongly associated with these resistant infections, underscoring the need for integrated metabolic management, molecular surveillance, and antimicrobial stewardship. These findings position glycemic control as a modifiable driver of antimicrobial resistance in DFUs.

diabetic foot ulcercarbapenem resistanceglycemic controlHbA1c
مراجعةمفتوح (مستودع)2026

Patient‐Derived Organoids in Functional Precision Oncology: Tumor Modeling, Drug‐Response Prediction, and Clinical Translation

Cell Biochemistry and Function · مجلد 44 (10) · e70321-e70321

Patient-derived organoids (PDOs) have emerged as an effective experimental platform for bridging the long-standing gap between traditional in vitro cancer models and the biological complexity of actual tumors. These three-dimensional cultures (3D), derived directly from patient tissues, preserve essential architectural, genomic, and phenotypic characteristics of their tumors of origin, enabling more accurate modeling of tumor heterogeneity and disease evolution. Over the last decade, rapid methodological advances in organoid culture systems, extracellular matrices (ECMs), and growth factor optimization have facilitated the establishment of organoid models for a wide range of malignancies and the development of large living biobanks representing diverse patient populations. These models are increasingly being utilized to study cancer biology, elucidate mechanisms of treatment resistance, and evaluate patient-specific therapeutic responses, highlighting their potential as tools for precision oncology. However, important challenges remain, including incomplete representation of the tumor microenvironment (TME), variability in culture conditions, and limited scalability, and the need for greater standardization and validation. Consequently, although PDOs show considerable promise for translational research and personalized medicine, their routine clinical implementation remains largely investigational, and their clinical utility has not yet been fully established. This review examines the technological foundations of PDO generation, assesses their role as experimental models of tumor biology, and discusses their expanding applications in translational cancer research and precision oncology while highlighting key challenges that must be addressed before their widespread clinical adoption.

patient-derived organoidsprecision oncologytumor heterogeneitydrug response prediction
مقالوصول مفتوح2026

Sustainable microbiology applications drive global progress toward the united nations sustainable development goals

Discover Sustainability · مجلد 7 (1)

Bio-based solutions are becoming more and more important in the shift to global sustainability. Sustainable microbiology becomes a crucial field that connects the Sustainable Development Goals (SDGs) of the UN with molecular mechanisms. The many functions of microorganisms as functional drivers of the 2030 Agenda are critically assessed in this review, which goes beyond the conventional view of them as pathogens to consider them as “biological infrastructure.” The development of biopesticides for food security (SDG 2), the engineering of exoelectrogenic biofilms for clean energy (SDG 7), and the optimization of metabolic flux in circular bioeconomies (SDG 12) are just a few of the major SDGs for which we examined the integration of microbial processes. “Structural Biotechnology,” where microbes help create self-healing urban environments (SDG 11) and act as carbon-sequestering allies in mitigating climate feedback loops (SDG 13), was given particular attention. This report also addressed the “Biotech Divide,” arguing that in order to achieve SDGs 10 (Reduced Inequalities) and 16 (Peace and Justice), biological infrastructure protection and fair access to genomic surveillance were essential in areas affected by conflict. Our results highlight the importance of maintaining microbial diversity for human health and economic resilience, rather than just as an environmental objective. The review concludes that interdisciplinary collaborations (SDG 17) that convert laboratory-scale bioprocesses into scalable, worldwide sustainability solutions are the only way to fully realize the potential of microbiology.

Sustainable Development Goalsbiopesticidesfood securityclean energy
مقالوصول مفتوح2026

Comparative phenotypic and genotypic analysis of distinct Pseudomonas aeruginosa T3SS effector genotypes

Frontiers in Cellular and Infection Microbiology · مجلد 16 · 1792519-1792519

Background Pseudomonas aeruginosa ( P. aeruginosa ) causes healthcare- and community-associated infections with high antimicrobial resistance and virulence diversity. The type III secretion system (T3SS) effectors genotypes ( exoS+, exoU+, exoT+, and exoY+ ) play central roles in pathogenesis, yet their relationships with antimicrobial resistance, virulence profiles, serotypes, and clinical manifestations remain incompletely defined. Methods Five hundred clinical specimens, sputum, urine, burn, wound, and eye exudates, 100 each, were collected from multiple hospitals for isolation of P. aeruginosa. Phenotypic and genotypic methods identified isolates and characterized T3SS effector genotypes, antimicrobial susceptibility, resistance genes, virulence genes, and serotypes. Clustering, strain typing, and correlation analyses assessed associations among resistance, virulence, epidemiology, and disease severity. Results Among 125 isolates, exoS+ was the most prevalent T3SS effector, followed by exoU+, while exoT+ and exoY+ were less frequent. The exoU+ isolates were consistently associated with severe clinical manifestations across specimen types and were more often hospital acquired, with enrichment for serotypes O6 and O11. The exoS+ isolates showed broader serotype diversity with balanced hospital and community acquisition, whereas ExoT and ExoY were mainly associated with O6 and O11, with ExoY more common in community-acquired cases but less prevalent overall. Despite widespread antimicrobial resistance and broad distribution of resistance genes, polymyxin remained the most effective agent, with a low resistance rate of 15.2%. Multidrug resistance affected 81.6% of isolates and was observed across all T3SS effector genotypes, with frequent coexistence of resistance and virulence genes within individual isolates. Hierarchical clustering revealed marked intra-group and inter-group heterogeneity, with no evidence of dominant clonal expansion by effector genotype or specimen type, and correlation analysis showed weak associations among resistance, virulence, serotypes, and epidemiological features, except for a consistent link between exoU+ and markers of severe tissue injury. Conclusions P. aeruginosa isolates form a heterogeneous, non-clonal population with independent resistance and virulence traits, while T3SS effector genotypes, especially exoU+, best predicts disease severity. The data suggest that pathogenicity in P. aeruginosa is driven by independently assorting resistance and virulence traits, not by fixed clonal backgrounds. These findings support integrating T3SS effector profiling into clinical risk assessment and surveillance.

Pseudomonas aeruginosatype III secretion systemexoSexoU
مقالوصول مفتوح2026

Effect of alone & combined application of benzylaminopurine and gibberellic acid on in-vitro germination and growth rate of broccoli

BMC Plant Biology · مجلد 26 (1)

Broccoli (Brassica oleraceae L. var. italica) is an important crop and faces challenges of further propagation due to genetic segregation and climate change. Efficient micropropagation protocols are necessary for the rapid production of true-to-type plantlets and are essential for this process. However, the synergistic effects of 6-benzylaminopurine (BAP) and gibberellic acid (GA₃) for this species have not been extensively studied. The study evaluated five pre-sowing seed-soaking treatments with various concentrations of BAP and GA₃ (Control: T₀; T₁: 25 + 25; T₂: 25 + 50; T₃: 50 + 25; T₄: 50 + 50 ppm) on Murashige and Skoog (MS) medium over a 16 h photoperiod, using a completely randomized design (CRD) with individual in vitro seedlings as experimental units. Morphological, physiological, biochemical, antioxidant, and gene expression (RT-qPCR) parameters were assessed.. All hormonal treatments significantly exhibited better response as compared to the control (T₀) treatment (p ≤ 0.05). The application of hormonal treatment (25 ppm BAP + 50 ppm GA3) (T2) significantly better response with an increase in shoot length and elevation in plant biomass, chlorophyll (a, b and T Chl), total phenolic content (TPC), flavonoids (TFC) and DPPH scavenging activity. Antioxidant enzymes, such as superoxide dismutase (SOD), catalase (CAT) and peroxidase (POD) and seedling vigor index (SVI-I, SVI-II) were significantly increased under T₂, markedly a mitigating enzyme activity. RT-qPCR analysis further confirmed these results by showing high levels of transcript abundance of antioxidant-related genes (BoSOD1, BoAPX1 and BoCAT) under T2 than in the control group with amplification specificity verified through melt curve analysis. Multivariate analyses, correlation heatmap, network analysis and principal component analysis indicated significant positive interrelationships among the growth traits, photosynthetic pigments, antioxidant capacity and vigor indices, implying the coordinated physiological regulation. Similarly, T2 as an efficient hormonal approach to enhance growth, antioxidant control, in vitro micropropagation efficiency in broccoli.

broccolibenzyladeninegibberellic acidseed soaking
مقالوصول مغلق2026

Ubiquitin in Human Diseases: Pathophysiology, Dysfunction and Treatment

Current Pharmaceutical Design · مجلد 32

Ubiquitin machinery is an essential regulatory system that maintains protein stability, degradation, and signalling by balancing ubiquitination and deubiquitination. In addition to its classical function in protein tagging for proteasomal degradation, ubiquitin has several essential cellular functions, including cell-cycle regulation, DNA repair, immunomodulation, intracellular signalling, and cellular stress responses. Abnormal regulation of this highly ordered system has been implicated in the pathogenesis of cancer, neurodegenerative diseases, infectious diseases, metabolic dysfunction, and autoimmunity. Recent developments in structural biology, chemical biology, and proteomics have increased our understanding of ubiquitin signalling and identified new therapeutic targets by revealing context-specific interactions within nodes of the ubiquitinproteasome system. Future approaches to restore proteostasis involve selective inactivation of proteasomal subunits, E3 ligases, and deubiquitinating enzymes (DUBs), as well as novel modalities such as proteolysistargeting chimeras (PROTACs) and molecular glues that redirect ubiquitin-dependent degradation of diseaserelevant proteins. Although preclinical and early clinical studies have demonstrated target specificity, longterm safety remains a challenge for clinical translation. This review provides an overview of ubiquitin's pathophysiological functions in key human diseases, therapeutic interventions, and the potential of ubiquitin-based therapeutic strategies for precision medicine and targeted drug therapy.

ubiquitinubiquitin-proteasome systemubiquitinationdeubiquitination
مراجعةوصول مفتوح202563استشهاد· Semantic Scholar

Detection of antimicrobial resistance via state-of-the-art technologies versus conventional methods

Frontiers in Microbiology · مجلد 16 · 1549044-1549044

Antimicrobial resistance (AMR) is recognized as one of the foremost global health challenges, complicating the treatment of infectious diseases and contributing to increased morbidity and mortality rates. Traditionally, microbiological culture and susceptibility testing methods, such as disk diffusion and minimum inhibitory concentration (MIC) assays, have been employed to identify AMR bacteria. However, these conventional techniques are often labor intensive and time consuming and lack the requisite sensitivity for the early detection of resistance. Recent advancements in molecular and genomic technologies-such as next-generation sequencing (NGS), matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), lateral flow immunoassays (LFIAs), PCR-based diagnostic methods, and CRISPR-based diagnostics-have revolutionized the diagnosis of AMR. These innovative approaches provide increased sensitivity, reduced turnaround times, and the ability to identify genetic resistance mechanisms. This review seeks to examine the advantages and disadvantages of both emerging technologies and traditional methods for detecting AMR, emphasizing the potential benefits and limitations inherent to each. By understanding the strengths and limitations of these technologies, stakeholders, including researchers, healthcare professionals, regulatory agencies, health authorities, financial managers, and patients, can make informed decisions aimed at preventing the emergence and dissemination of antibiotic-resistant strains, thereby ultimately increasing patient safety.

antimicrobial resistanceantibiotic resistance detectionnext-generation sequencingMALDI-TOF mass spectrometry
مراجعةوصول مفتوح202525استشهاد· Semantic Scholar

An update on the molecular mechanisms underlying the progression of miR-21 in oral cancer

World Journal of Surgical Oncology · مجلد 23 (1) · 73-73

Globally, oral cancer ranks among the top ten cancers, with a higher prevalence in lower-income countries, where risk factors such as tobacco use, excessive alcohol consumption, and poor oral hygiene are widespread. Metastasis plays a critical role in cancer progression. miR-21 is a crucial regulator of cancer metastasis, profoundly influencing cellular and molecular pathways that contribute to tumour aggressiveness. As a microRNA, miR-21 downregulates tumour suppressor genes, promoting cell proliferation, survival, invasion, and migration. Its role in epithelial-mesenchymal transition (EMT) further facilitates metastatic behaviour. miR-21 also modulates the tumour microenvironment by promoting angiogenesis and altering immune responses, thus enhancing cancer progression.Moreover, miRNA - 21 influences the various signalling pathways like PI3K/ AKT, TGF-β, NF-κB, and STAT3, as well as involved in the cell fate mechanisms known as Autophagy and apoptosis. Clinically, elevated miR-21 levels are associated with poor prognosis, advanced tumour stages, and decreased survival rates, making it a valuable prognostic marker. Additionally, miR-21 expression levels can predict resistance to chemotherapy and targeted therapies, aiding in personalized treatment planning. Therapeutically, targeting miR-21 through anti-miR-21 oligonucleotides, small molecule inhibitors, and miRNA sponges shows promise in pre-clinical studies, potentially inhibiting tumour growth and improving sensitivity to existing treatments. Overall, miR-21's multifaceted role in cancer biology, its prognostic and predictive value, and its potential as a therapeutic target highlight its significance in advancing cancer diagnosis, treatment, and patient outcomes. Further research and clinical trials are essential to exploit miR-21's capabilities in oncology fully.

miR-21oral cancermicroRNAmetastasis
مقالوصول مفتوح202512استشهاد· Semantic Scholar

Exploring therapeutic paradigm focusing on genes, proteins, and pathways to combat leprosy and tuberculosis: A network medicine and drug repurposing approach

Journal of Infection and Public Health · مجلد 18 (6) · 102763-102763

Leprosy and tuberculosis caused by Mycobacterium leprae and Mycobacterium tuberculosis, respectively, are chronic infections with significant public health implications. While leprosy affects the skin and peripheral nerves and tuberculosis primarily targets the lungs, both diseases involve systemic immune responses. This study integrates transcriptomic analysis cheminformatics and molecular dynamics simulations to identify molecular mechanisms and potential therapeutic targets. Transcriptomic datasets were analyzed to identify dysregulated genes and pathways. Pathway enrichment tissue-specific and bulk RNA-seq expression analyses provided biological context. System biology networks revealed regulatory hub genes and molecular docking studies evaluated CHEMBL compounds as potential therapeutics. Molecular dynamics (MD) simulations assessed the stability of top ligand-protein complexes through RMSD RMSF and MM-GBSA free energy calculations. Gene expression analysis identified 13 core dysregulated genes, including HSP90AA1 MAPK8IP3 and ZMPSTE24. Tissue-specific expression localized pivotal genes to lung tissues and immune cells with HSP90AA1 highly expressed in alveolar macrophages and epithelial cells. HSP90AA1 gene emerged as a central hub gene with 96 interactions involved in stress response pathways. Docking studies identified CHEMBL3653862 and CHEMBL3653884 with strong binding affinities (-10.16 to −12.69 kcal/mol) interacting with Asp93 and Tyr139. MD simulations confirmed binding stability with RMSD fluctuations within 2.1–3.5 Å and MM-GBSA energy values supporting ligand-protein stability. This study identifies HSP90AA1 as a potential drug target in leprosy and tuberculosis. Findings support host-directed therapy approaches and highlight the importance of computational modeling in accelerating drug discovery. The study provides a foundation for future experimental validation, including in vitro and in vivo testing to advance drug repurposing strategies for these chronic infections. • Identified 13 shared dysregulated genes between tuberculosis and leprosy. • Uncovered critical pathways and protein-protein interactions using network medicine. • Highlighted roles of genes in immune-related cells through tissue-specific and single-cell gene expression analyses. • Conducted drug repurposing analysis, identifying CHEMBL compounds with strong binding affinities for key targets. • Deliver a comprehensive understanding of disease mechanisms and therapeutic opportunities.

leprosytuberculosisMycobacterium lepraeMycobacterium tuberculosis